Mengjun Yu
Chongqing, 400037, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to 'Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer' [Mater. Today Bio 33 (2025) 101993].
Journal: Materials today. Bio
Published: April 02, 2026
Artesunate-based macromolecular therapy attenuates neutrophilic asthma by targeting the BCAT1/Succinate/NLRP3 metabolite-immunity cascade.
Journal: Journal of nanobiotechnology
Published: February 26, 2026
Self-assembled manganese-based nanoplatforms synergizing immunogenic cell death and STING activation for triple-negative breast cancer.
Journal: Materials today. Bio
Published: February 01, 2026
Cascade-targeting oxygen-self-supplying nano-photosensitizer for enhanced photodynamic immunotherapy of triple-negative breast cancer.
Journal: Acta biomaterialia
Published: December 08, 2025
Co-delivery of endoplasmic reticulum-targeted photosensitizer and Ido-1 inhibitor potentiates immunotherapeutic efficacy in triple-negative breast cancer.
Journal: Materials today. Bio
Published: November 01, 2025
Co-Delivery Evodiamine-Porphyrin Nano-Drug to Enhance Photodynamic-Chemo-Immunotherapy for Triple-Negative Breast Cancer Treatment.
Journal: Advanced healthcare materials
Published: June 16, 2025
Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer.
Journal: Materials today. Bio
Published: February 14, 2025
Evodiamine encapsulated by hyaluronic acid modified zeolitic imidazolate framework-8 for tumor targeted therapy.
Journal: Drug delivery and translational research
Published: June 11, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026